Marvel Biosciences Shares Positive Results of MB204 in the Oprm1 Model of Autism

          Marvel Biosciences Shares Positive Results of MB204 in the Oprm1 Model of AutismOctober 10, 2024 9:00 AM EDT | Source: Marvel Biosciences Corp.Calgary, Alberta--(Newsfile Corp. - October 10, 2024) - Marvel Biosciences Corp. (TSXV: MRVL) (OTCQB: MBCOF), and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"), today shared promising results from a recent study on MB204. The research was conducted by Drs. Julie Le Merrer and Jerome Becker of the iBraiN  ...